Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
This study has been completed.
Sponsor:
Fudan University
Information provided by:
Fudan University
ClinicalTrials.gov Identifier:
NCT00601159
First received: December 26, 2007
Last updated: July 1, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |